Search Results - F. T. Ageev
- Showing 1 - 20 results of 31
- Go to Next Page
-
1
Modern concept of diastolic heart failure by F. T. Ageev
Published 1970-01-01The paper discusses modern aspects of epidemiology, pathogenesis, clinical course, diagnostics, and treatment of the patients with chronic heart failure (CHF) and intact left ventricular ejection fraction (LVEF). CHF with intact LVEF comprises over 50% of all CHF cases, and is more prevalent in elde...
Get full text
Article -
2
Left ventricular hypertrophy: prognostic value, pathogenesis, possible remodeling: focusing on angiotensin receptor antagonists by M. D. Smirnova, F. T. Ageev
Published 2007-12-01Left ventricular hypertrophy (LVH) is regarded as the main predictor of cardiovascular mortality. “Remodeling” term, preceded by “LVH”, includes the whole complex of multi!level changes, from macroscopic to biochemical and genetic, associated with diastolic and systolic myocardial dysfunction, myoca...
Get full text
Article -
3
Clinical Efficacy and Tolerability of Antihypertensive Therapy with Single Pill Combinations of Telmisartan in Patients with Arterial Hypertension in Clinical Practice According to... by F. T. Ageev, M. D. Smirnova
Published 2023-01-01Aim. To assess the clinical outcomes and tolerability of antihypertensive therapy with single pill combinations (SPC) amlodipine + telmisartan and hydrochlorothiazide + telmisartan in clinical practice.Material and methods. Patients with hypertension of grade 1-3 (n=13647; 57.6% women; age 59.3±11.4...
Get full text
Article -
4
Heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus: pathophysiology and treatment options by A. A. Borisov, A. D. Gvozdeva, F. T. Ageev
Published 2021-07-01Type 2 diabetes mellitus is known to increase the risk of the development of heart failure with preserved ejection fraction and worsen its symptoms. To date, no specific treatment has been shown to reduce morbidity and mortality in patients with heart failure with preserved ejection fraction. In thi...
Get full text
Article -
5
Patient adherence after coronary bypass grafting: different facets of same matter. A systematic review by T. V. Fofanova, M. V. Subotnikov, F. Т. Ageev
Published 2021-08-01Background. Adherence in cardiological patients is a leading challenge due to a high society burden imposed by cardiovascular diseases (CVDs) through morbidity, reduced life expectancy, disability and high mortality rates in population. Despite the availability of highly effective medicines and high...
Get full text
Article -
6
Coadministration of Cardiomagnyl with Edarbi/Edarbi Clo in comparison with enteric-coated acetylsalicylic acid and renin-angiotensin-aldosterone system blockers in patients with hy... by F. T. Ageev, M. D. Smirnova, A. N. Kaftanov, D. V. Gavrilov
Published 2025-07-01Aim. To compare clinical outcomes in patients with hypertension and atherosclerotic cardiovascular diseases (CVDs) prescribed a combination of buffered acetylsalicylic acid (BA) (Cardiomagnyl®) + Azilsartan/Azilsartan+chlorthalidone (Edarbi/Edarbi Clo®) or enteric-coated acetylsalicylic acid (ECA) +...
Get full text
Article -
7
Heart rate reduction as a therapeutic goal: focus on primary prevention by Yu. A. Orlova, G. V. Makarova, G. V. Mikhailova, F. T. Ageev
Published 2012-02-01Recently published studies have demonstrated a direct link between heart rate (HR) and prognosis across various populations and clinical groups, including elderly people, patients with arterial hypertension, myocardial infarction, and coronary artery stenting, overweight patients, or even young peop...
Get full text
Article -
8
Left ventricular hypertrophy: renin4angiotensin system role by F. T. Ageev, A. G. Ovchinnikov, V. M. Serbul, Yu. N. Belenkov
Published 2008-04-01The review presents modern views on pathogenetic mechanisms of myocardial hypertrophy, with the key role played by renin-angiotensin system (RAS) activation and hemodynamic overload. The authors analyze main structural and functional disturbances typical for and underlying the clinical manifestation...
Get full text
Article -
9
Reproducibility of instantaneous wave-free ratio and angiography coregistration in patients with coronary heart disease and diffuse and multilevel coronary artery lesion by D. S. Bubnov, R. V. Atanesyan, Z. B. Kardanakhishvili, F. T. Ageev, Yu. G. Matchin
Published 2023-11-01Aim. To determine the reproducibility of the results of instantaneous wavefree ratio (iFR) and angiography coregistration in patients with coronary heart disease (CAD) with multilevel and diffuse lesions of the coronary arteries.Materials and methods. The study included 34 patients with chronic isch...
Get full text
Article -
10
Guidelines for nurses and patients with chronic heart failure by S. A. Boytsov, F. T. Ageev, Z. N. Blankova, O. N. Svirida, Yu. L. Begrambekova
Published 2021-02-01These guidelines were developed to improve the outpatient care service for patients with chronic heart failure by creating specialized offices in the structure of first-level medical organizations, whose staff includes specialized personnel of both senior and middle medical level.
Get full text
Article -
11
Potential of valsartan+sacubitril therapy in hypertensive heart disease by A. G. Ovchinnikov, A. D. Gvozdeva, A. V. Potekhina, M. V. Vitsenya, F. T. Ageev
Published 2021-08-01The course of hypertension is often complicated by left ventricular hypertrophy (or hypertensive heart disease, HHD). The main “corridor” of natural HHD is development of heart failure with preserved ejection fraction (HFpEF). With HFpEF, the bioavailability of natriuretic peptides (NP) is significa...
Get full text
Article -
12
Algorithm for predicting cardiovascular events in low/moderate risk patients using traditional and new factors: data from 10-year follow-up study by M. D. Smirnova, O. N. Svirida, T. V. Fofanova, Z. N. Blankova, E. B. Yarovaya, F. T. Ageev
Published 2021-10-01Aim. To create an advanced algorithm for predicting cardiovascular events (CVE) in low/moderate risk patients using a complex of traditional and new factors.Material and methods. The study included 700 patients with Systematic Coronary Risk Evaluation (SCORE) <5%, examined in 20092010. In add...
Get full text
Article -
13
Improving outpatient care in chronic heart failure by S. A. Boytsov, F. T. Ageev, O. N. Svirida, Z. N. Blankova, Yu. L. Begrambekova, O. M. Reitblat
Published 2021-08-01Despite advances in pharma and high-technology medicine, the rate of burdensome hospital admissions and mortality in patients with chronic heart failure (CHF) remains high. Over half of all admission-entailing decompensations have been repeatedly shown to emerge from non-compliance with outpatient p...
Get full text
Article -
14
ASSOCIATIONS BETWEEN CLINICAL COURSE, LEFT VENTRICULAR HYPERTROPHY SEVERITY AND ACE GENE I/D POLYMORPHISM IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY AND HYPERTENSIVE HEART by M. D. Smirnova, T. V. Fofanova, Z. B. Khasanova, A. G. Ovchinnikov, F. T. Ageev, A. Yu. Postnov
Published 2009-04-01The manifold studies on ACE gene impact on left ventricular hypertrophy (LVH) development in hypertrophic cardiomyopathy (HCMP) and arterial hypertension (AH) have provided too contradictory results to clarify the association between ACE gene I/D polymorphism and cardiovascular pathology in these no...
Get full text
Article -
15
Subclinical depression and anxiety as an additional risk factor for cardiovascular events in low- and moderate-risk patients: data from 10-year follow-up by M. D. Smirnova, O. N. Svirida, T. V. Fofanova, Z. N. Blankova, E. B. Yarovaya, F. T. Ageev, S. A. Boytsov
Published 2021-07-01Aim. To assess the contribution of anxiety (A) and depression (D) to the increased risk of cardiovascular events (CVEs) in patients with Systematic Coronary Risk Evaluation (SCORE) <5% according to 10-year follow-up.Material and methods. The work included 190 patients with SCORErisk <5...
Get full text
Article -
16
What “new” factors should be considered when assessing cardiovascular risk? by M. D. Smirnova, I. V. Barinova, T. V. Fofanova, Z. N. Blankova, O. N. Svirida, F. T. Ageev, S. A. Boytsov
Published 2018-12-01One of the causes of high mortality from cardiovascular diseases is the lack of effective measures for the primary and secondary prevention of cardiovascular complications (CCO), due to the difficulty of timely identification risk factors (RF) and individuals with a high individual risk of CCO. This...
Get full text
Article -
17
EFFICACY OF A FIXED COMBINATION OF LOSARTAN AND AMLODIPINE IN PATIENTS WITH ARTERIAL HYPERTENSION: SEASONAL FEATURES by M. D. Smirnova, T. V. Fofanova, Z. N. Blankova, M. V. Vitsenya, T. V. Tsybulskaya, Yu. F. Dianova, F. T. Ageev
Published 2017-06-01The goal is to evaluate the efficacy and security of treatment of patients with arterial hypertension (AH) during the heat wave of a fixed combination of ARBS+ACC (losartan+amlodipine).Materials and methods. Included 26 patients with hypertension 1 and 2 degrees from 42 to 81 years. All patients und...
Get full text
Article -
18
HEALTH EFFECTS OF HOT SUMMER WEATHER IN PATIENTS WITH INTERMEDIATE AND HIGH CARDIOVASCULAR RISK by M. D. Smirnova, F. T. Ageev, O. N. Svirida, L. G. Ratova, G. G. Konovalova, A. K. Tikhadze, V. Z. Lankin
Published 2013-08-01Background. The potential global warming justifies the need for further investigation of the impact of abnormally hot summer weather on health and the prevention of these negative health effects.Aim. To study the effects of extreme climatic conditions (hot weather) on hemodynamics, electrolyte metab...
Get full text
Article -
19
EVALUATION OF THE SHORT-TERM AND DELAYED RISKS OF THE ABNORMAL SUMMER 2010 HEAT IMPACT IN SEVERAL DISTRICTS OF NIZHNY NOVGOROD OBLAST, CLOSE TO WILDFIRES, ON THE MORBIDITY AND MORT... by M. D. Smirnova, Yu. V. Badin, O. Yu. Badina, A. R. Vaisberg, D. S. Polyakov, E. V. Shcherbinina, F. T. Ageev, F. T. Fomin
Published 2015-12-01The influence of abnormal summer heat (AH) in the year 2010 on morbidity and mortality in Russian Federation regions is not studied good enough. Nizhny Novgorod Oblast was one of the most involved and harmed.Aim. Retrospective assessment of short- and long-term influence of AH and fires of the summe...
Get full text
Article -
20
Zofenopril in the treatment of patients with arterial hypertension and stable coronary heart disease: effects on oxidative stress and flowdependent vasodilatation by F. T. Ageev, A. G. Ovchinnikov, A. G. Plisyuk, N. E. Arzamastseva, B. D. Kulev, A. E. Kuz’mina, I. F. Patrusheva
Published 2011-06-01Aim. To compare the effects of ACE inhibitors zofenopril and perindopril on endothelial function and oxidative stress (OS) in patients with stable CHD and AH. Material and methods. In total, 40 patients with stable CHD (Functional Class II-III effort angina) and Stage 1-2 AH received zofenopril (7,5...
Get full text
Article